Normalizing Lung Cancer Screening: Expert Weighs In
BY Gina Columbus
Pierre Massion, M.D., sat down with CURE to discuss lung cancer screening and prevention.
Examining the Role of Blood-Based Biomarkers in Lung Cancer
BY Gina Columbus
Blood-based biomarkers are moving into the realm of non-small cell lung cancer (NSCLC), and while tissue biopsies are still the standard, if plasma assays are positive, they can be helpful in deciding the first-line treatment that patients should receive.
Patients with Lung Cancer Have Risk of Cancer-Associated Suicide
BY Allie Casey
The rate of patients with lung cancer who commit suicide is higher than those with other types of tumors. A recent study examined why.
Combination Approved for BRAF-Positive Lung Cancer
BY Jason Harris
The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) gained approval from the Food and Drug Administration (FDA) for the treatment of patients with BRAF V600–positive advanced or metastatic non–small cell lung cancer (NSCLC).
Senate Releases Plan for Repealing Affordable Care Act, as Cancer Advocates Weigh In
BY Allie Casey
This morning, Senate Republican leaders released the draft of a bill to repeal and replace the Affordable Care Act (Obamacare).
Improving Response in Lung Cancer With CNS Metastases
BY Wayne Kuznar
Tagrisso (osimertinib) had positive outcomes for patients with T790M-positive non–small cell lung cancer (NSCLC) for central nervous system (CNS) metastases.
Expert Discusses The Future of EGFR+ and ALK+ Lung Cancer
BY Gina Columbus
There may be an upcoming shift in the treatment paradigm of patients with EGFR+ and ALK+ lung cancer.
Surgery Is Still Key in Lung Cancer Treatment
BY Gina Columbus
While new treatments continue to move into the realm of lung cancer treatment, surgery is still a mainstay, says Eric Lambright, M.D.
FDA Approves Zykadia for Metastatic Non-Small Cell Lung Cancer
BY Jason M. Broderick
Zykadia was granted FDA approval for the treatment of some patients with non-small cell lung cancer.
More Early Cancers Diagnosed After the Affordable Care Act
BY Allie Casey
After the Affordable Care Act was passed, a study found that there were more stage 1 cancer diagnoses across the nation.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Lung CURE discussion group.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Non-Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of non-small cell lung cancer.
Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of small cell lung cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Lung Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Lung Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for lung cancer.